12/18/2024
7:27 AM | Javitt Jonathan C (Reporting)
NRX Pharmaceuticals, Inc. (Issuer)
NRx Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/22/2024
12:44 PM | ABRAMS MICHAEL S (Reporting)
NRX Pharmaceuticals, Inc. (Issuer)
NRx Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
11/20/2024
8:00 AM | NRX Pharmaceuticals, Inc. (Filer)
NRx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/15/2024
4:24 PM | NRX Pharmaceuticals, Inc. (Filer)
NRx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
11:21 AM | NRX Pharmaceuticals, Inc. (Filer)
NRx Pharmaceuticals (Filer)
| Form S-1
Registration statement under Securities Act of 1933 | |
10/31/2024
7:00 AM | NRX Pharmaceuticals, Inc. (Filer)
NRx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/15/2024
3:52 PM | NRX Pharmaceuticals, Inc. (Filer)
NRx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
10/11/2024
3:53 PM | NRX Pharmaceuticals, Inc. (Filer)
NRx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/05/2024
3:18 PM | NRX Pharmaceuticals, Inc. (Filer)
NRx Pharmaceuticals (Filer)
| Form DEF 14A | |
08/20/2024
3:38 PM | NRX Pharmaceuticals, Inc. (Filer)
NRx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2024
4:27 PM | NRX Pharmaceuticals, Inc. (Filer)
NRx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2024
3:39 PM | NRX Pharmaceuticals, Inc. (Filer)
NRx Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/12/2024
4:15 PM | NRX Pharmaceuticals, Inc. (Filer)
NRx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/27/2024
3:58 PM | NRX Pharmaceuticals, Inc. (Filer)
NRx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/26/2024
6:37 PM | McBride Dennis (Reporting)
NRX Pharmaceuticals, Inc. (Issuer)
NRx Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
06/20/2024
4:03 PM | NRX Pharmaceuticals, Inc. (Filer)
NRx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/30/2024
4:26 PM | NRX Pharmaceuticals, Inc. (Filer)
NRx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/29/2024
3:46 PM | NRX Pharmaceuticals, Inc. (Filer)
NRx Pharmaceuticals (Filer)
| Form 10-K/A | |
04/19/2024
4:10 PM | NRX Pharmaceuticals, Inc. (Filer)
NRx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/19/2024
9:08 AM | NRX Pharmaceuticals, Inc. (Filer)
NRx Pharmaceuticals (Filer)
| Form 424B5 | |
04/18/2024
7:21 AM | NRX Pharmaceuticals, Inc. (Filer)
NRx Pharmaceuticals (Filer)
| Form 424B5 | |
04/15/2024
4:22 PM | NRX Pharmaceuticals, Inc. (Filer)
NRx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/15/2024
4:13 PM | NRX Pharmaceuticals, Inc. (Filer)
NRx Pharmaceuticals (Filer)
| Form 424B3 | |
04/15/2024
5:00 AM | NRX Pharmaceuticals, Inc. (Filer)
NRx Pharmaceuticals (Filer)
| Form 424B3 | |
04/02/2024
5:01 AM | NRX Pharmaceuticals, Inc. (Filer)
NRx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/29/2024
4:18 PM | NRX Pharmaceuticals, Inc. (Filer)
NRx Pharmaceuticals (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/21/2024
4:09 PM | NRX Pharmaceuticals, Inc. (Filer)
NRx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/13/2024
4:08 PM | NRX Pharmaceuticals, Inc. (Filer)
NRx Pharmaceuticals (Filer)
| Form DEFA14A | |
03/11/2024
4:16 PM | NRX Pharmaceuticals, Inc. (Filer)
NRx Pharmaceuticals (Filer)
| Form DEF 14A | |
02/28/2024
4:09 PM | NRX Pharmaceuticals, Inc. (Filer)
NRx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/28/2024
9:40 AM | NRX Pharmaceuticals, Inc. (Filer)
NRx Pharmaceuticals (Filer)
| Form 424B5 | |
02/26/2024
4:15 PM | NRX Pharmaceuticals, Inc. (Filer)
NRx Pharmaceuticals (Filer)
| Form 424B5 | |
02/14/2024
5:03 AM | NRX Pharmaceuticals, Inc. (Filer)
NRx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/02/2024
3:37 PM | NRX Pharmaceuticals, Inc. (Filer)
NRx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/23/2024
3:16 PM | NRX Pharmaceuticals, Inc. (Filer)
NRx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/16/2024
5:36 PM | NRX Pharmaceuticals, Inc. (Issuer)
NRx Pharmaceuticals (Issuer)
Rehnquist Janet (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/29/2023
3:30 PM | NRX Pharmaceuticals, Inc. (Filer)
NRx Pharmaceuticals (Filer)
| Form PRE 14A | |
12/29/2023
3:15 PM | NRX Pharmaceuticals, Inc. (Filer)
NRx Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
